2012
DOI: 10.1089/dia.2012.0097
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Metformin Glycinate on Glycated Hemoglobin A1c Concentration and Insulin Sensitivity in Drug-Naive Adult Patients with Type 2 Diabetes Mellitus

Abstract: Administration of metformin glycinate during a 2-month period showed a greater decrease in A1C concentrations than placebo in a selected group of drug-naive adult patients with T2DM.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…Another meta-analysis has obtained similar results. 18 Metformin was thought to improve the reduced insulin sensitivity in overweight subjects, 19 prediabetes, 20 patients with T2DM, 21 and patients with T1DM. 22 In our metaanalysis, metformin administration significantly decreased the daily insulin dose requirement, indicating that metformin might improve the insulin sensitivity in T1DM.…”
Section: Discussionmentioning
confidence: 99%
“…Another meta-analysis has obtained similar results. 18 Metformin was thought to improve the reduced insulin sensitivity in overweight subjects, 19 prediabetes, 20 patients with T2DM, 21 and patients with T1DM. 22 In our metaanalysis, metformin administration significantly decreased the daily insulin dose requirement, indicating that metformin might improve the insulin sensitivity in T1DM.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the 1.1-point reduction in HbA 1c is comparable to expected reductions from metformin therapy 16 ; thus, in some patients, drug therapy may be delayed with this intervention. In addition, while current guidelines still encourage prescription of statin medications as well as angiotensin-converting enzyme inhibitors for most patients with diabetes, values of both LDL and SBP were lower in the intervention group.…”
Section: Resultsmentioning
confidence: 84%
“…Additionally, it is reported to activate the 5′-AMP-activated protein kinase in different tissues, chiefly in liver leading to enhanced insulin sensitivity. 27,28 Role of metformin in reducing blood pressure levels in patients with T2DM is variable; however, a potential of metformin in lowering blood pressure in patients with impaired glucose tolerance or impaired fasting glucose is an established evidence. 4,29,30 In addition, metformin therapy is also linked to improvements in lipoprotein metabolism, as well as in cardiovascular mechanisms such as endothelial dysfunction, oxidative stress, and fat redistribution.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, it is reported to activate the 5′-AMP-activated protein kinase in different tissues, chiefly in liver leading to enhanced insulin sensitivity. 27 , 28 …”
Section: Discussionmentioning
confidence: 99%